TRENTON, ME--(MARKET WIRE)--Sep 5, 2007 -- Bar Harbor BioTechnology Inc. has completed a multimillion dollar Series A financing in time to fund its first product launch scheduled for October 1st, 2007. The company develops new products for scientists to perform gene expression experiments using real-time quantitative polymerase chain reactions, or qPCR.
